Back to NBIX

ARMISTICE CAPITAL, LLC → NBIX

ARMISTICE CAPITAL, LLC NBIX Position History

Neurocrine Biosciences, Inc. • Healthcare

Quarters held
6
Latest value
$70.9M
Q3 2026
Peak value
$116.3M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$97.8M
Q4 2025$116.3M
Q1 2026$95.4M
Q2 2026$90.3M
Q3 2026$80.2M
Q3 2026$70.9M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$70.9M500.0K——
Q3 2026$80.2M565.3K——
Q2 2026$90.3M535.8K——
Q1 2026$95.4M724.0K——
Q4 2025$116.3M820.2K——
Q3 2025$97.8M697.0K——

Other funds holding NBIX

Other ARMISTICE CAPITAL, LLC positions

PTCT

PTC THERAPEUTICS INC

$212.8M
PTCT

PTC THERAPEUTICS ORD

$201.1M
TVTX

TRAVERE THERAPEUTICS ORD

$160.7M
IMVT

IMMUNOVANT INC

$146.1M
TVTX

TRAVERE THERAPEUTICS INC

$145.5M
TVTX

TRAVERE THERAPEUTICS INC

$143.8M
PTCT

PTC THERAPEUTICS INC

$141.3M
SUPN

SUPERNUS PHARMACEUTICALS INC

$137.4M